Free Trial

Adagio Medical (ADGM) Competitors

$3.07 -0.64 (-17.25%)
(As of 11/15/2024 ET)

ADGM vs. TLSI, INO, KRMD, GUTS, QIPT, SRTS, LNSR, TMDIF, WOK, and MGRM

Should you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include TriSalus Life Sciences (TLSI), Inovio Pharmaceuticals (INO), KORU Medical Systems (KRMD), Fractyl Health (GUTS), Quipt Home Medical (QIPT), Sensus Healthcare (SRTS), LENSAR (LNSR), Titan Medical (TMDIF), WORK Medical Technology Group LTD Ordinary Shares (WOK), and Monogram Orthopaedics (MGRM). These companies are all part of the "surgical & medical instruments" industry.

Adagio Medical vs.

TriSalus Life Sciences (NASDAQ:TLSI) and Adagio Medical (NASDAQ:ADGM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Adagio Medical has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -219.71%.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-219.71% N/A -192.99%
Adagio Medical N/A N/A -12.35%

TriSalus Life Sciences received 10 more outperform votes than Adagio Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
TriSalus Life SciencesOutperform Votes
10
100.00%
Underperform Votes
No Votes
Adagio MedicalN/AN/A

In the previous week, TriSalus Life Sciences had 19 more articles in the media than Adagio Medical. MarketBeat recorded 20 mentions for TriSalus Life Sciences and 1 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.89 beat TriSalus Life Sciences' score of 0.78 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Overall Sentiment
TriSalus Life Sciences Positive
Adagio Medical Very Positive

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 32.8% of TriSalus Life Sciences shares are held by insiders. Comparatively, 53.5% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Adagio Medical has lower revenue, but higher earnings than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$18.51M6.47-$59.04M-$2.50-1.57
Adagio MedicalN/AN/A-$2.13MN/AN/A

TriSalus Life Sciences currently has a consensus price target of $12.08, suggesting a potential upside of 207.46%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than Adagio Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Adagio Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

TriSalus Life Sciences has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of -0.09, meaning that its stock price is 109% less volatile than the S&P 500.

Summary

TriSalus Life Sciences beats Adagio Medical on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$41.11M$4.55B$5.07B$8.69B
Dividend YieldN/A39.54%5.01%4.06%
P/E RatioN/A24.52118.8717.39
Price / SalesN/A55.201,271.9590.06
Price / CashN/A51.7740.2636.41
Price / Book-0.885.616.305.86
Net Income-$2.13M$13.76M$119.26M$225.66M
7 Day Performance22.31%-3.79%-3.69%-1.20%
1 Month Performance14.55%3.10%-0.35%3.29%
1 Year PerformanceN/A50.28%32.11%24.30%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
N/A$3.07
-17.3%
N/AN/A$41.11MN/A0.0085Positive News
High Trading Volume
TLSI
TriSalus Life Sciences
4.4268 of 5 stars
$4.48
flat
N/A+0.2%$136.60M$24.74M-1.79106Analyst Forecast
Analyst Revision
News Coverage
Gap Up
INO
Inovio Pharmaceuticals
3.6705 of 5 stars
$5.17
-3.2%
N/A-91.2%$134.23M$591,858.000.00127Analyst Forecast
News Coverage
Gap Up
KRMD
KORU Medical Systems
3.0035 of 5 stars
$2.88
-0.3%
N/A+33.9%$132.05M$28.52M-11.5280Analyst Forecast
News Coverage
Gap Up
GUTS
Fractyl Health
1.6923 of 5 stars
$2.56
+2.0%
N/AN/A$122.70M$120,000.000.00102Earnings Report
Insider Selling
News Coverage
QIPT
Quipt Home Medical
3.2818 of 5 stars
$2.73
+0.4%
N/A-46.2%$117.64M$255.81M-24.821,200
SRTS
Sensus Healthcare
4.1001 of 5 stars
$6.99
-0.9%
N/A+264.5%$114.57M$24.41M17.0540Analyst Forecast
News Coverage
LNSR
LENSAR
3.0626 of 5 stars
$7.34
-0.5%
N/A+224.3%$85.20M$45.12M-5.03110Short Interest ↓
TMDIF
Titan Medical
N/A$0.71
-2.7%
N/A+977.1%$81.32M$17.63M-0.574News Coverage
Gap Down
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/A$5.45
-3.9%
N/AN/A$79.03M$9.86M0.00226Positive News
MGRM
Monogram Orthopaedics
0.9558 of 5 stars
$2.20
+0.9%
N/A-20.9%$76.32M$364,999.00-6.4728Upcoming Earnings
News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners